Nurix Therapeutics (NRIX) Q4 2024 Earnings

11OctConfirmed
Q4 2023
Q1 2024
Q3 2024
Q4 2024
-0.78
-0.71
-0.64
-0.57

Details

Expected EPS
-0.687692
Actual EPS
-0.67
Surprise EPS
0.02
Surprise Percent
+2.57%

Description

Nurix Therapeutics (NRIX) has reported earnings of -0.67 per share for Q4 2024.

0 Comments

Share your thoughts